The RWE Oncology Market is expected to grow at a CAGR of 14.2% from 2022–2029 to reach $1.65 billion by 2029. The growth of this market is driven by factors such as the rising prevalence of cancer, rapidly growing big
The U.S. Real World Evidence Solutions Market is projected to reach $2.01 billion by 2028, at a CAGR of 13.1% from 2021 to 2028. The growth of this market is driven by the rising prevalence of